{"id":"enoxacin","rwe":[{"pmid":"41883118","year":"2026","title":"In vitro and preclinical assessment of drug interactions between fluoroquinolones and a non-steroidal anti-inflammatory drug predicting risk of seizure.","finding":"","journal":"Toxicological sciences : an official journal of the Society of Toxicology","studyType":"Clinical Study"},{"pmid":"41792996","year":"2026","title":"Cell-free miRNAs are pharmacodynamic biomarkers for enhanced DICER activity by enoxacin in human patients with ALS.","finding":"","journal":"Molecular therapy : the journal of the American Society of Gene Therapy","studyType":"Clinical Study"},{"pmid":"41765558","year":"2026","title":"Copper ion-antibiotic complexation inhibits photochemical transformation of fluoroquinolones via electron redistribution and reactivity regulation.","finding":"","journal":"Journal of environmental sciences (China)","studyType":"Clinical Study"},{"pmid":"41748289","year":"2026","title":"Canonical microRNA loss drives tumor development implicating therapeutic efficacy of enoxacin in angiosarcoma.","finding":"","journal":"RNA (New York, N.Y.)","studyType":"Clinical Study"},{"pmid":"41729907","year":"2026","title":"Flexible Organic Clip as an Adapter to Enhance Host-Guest Nanopore Single-Molecule Sensing.","finding":"","journal":"Analytical chemistry","studyType":"Clinical Study"}],"tags":[{"label":"enoxacin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"RISC-loading complex subunit TARBP2","category":"target"},{"label":"TARBP2","category":"gene"},{"label":"ATP6V1B2","category":"gene"},{"label":"J01MA04","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Acute gonococcal cervicitis","category":"indication"},{"label":"Acute gonococcal urethritis","category":"indication"},{"label":"Gonorrhea","category":"indication"},{"label":"Gonorrhea of pharynx","category":"indication"},{"label":"Gonorrhea of rectum","category":"indication"},{"label":"Urinary tract infectious disease","category":"indication"},{"label":"Approved 1990s","category":"decade"},{"label":"Anti-Bacterial Agents","category":"pharmacology"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Antineoplastic Agents","category":"pharmacology"},{"label":"Cytochrome P-450 CYP1A2 Inhibitors","category":"pharmacology"},{"label":"Cytochrome P-450 Enzyme Inhibitors","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Metabolic Side Effects of Drugs and Substances","category":"pharmacology"},{"label":"Topoisomerase II Inhibitors","category":"pharmacology"},{"label":"Topoisomerase Inhibitors","category":"pharmacology"}],"phase":"marketed","safety":{"drugInteractions":[{"url":"/drug/famotidine","drug":"famotidine","action":"Monitor closely","effect":"May interact with Famotidine","source":"DrugCentral","drugSlug":"famotidine"},{"url":"/drug/magnesium-hydroxide","drug":"magnesium hydroxide","action":"Monitor closely","effect":"May interact with Magnesium Hydroxide","source":"DrugCentral","drugSlug":"magnesium-hydroxide"},{"url":"/drug/magnesium-oxide","drug":"magnesium oxide","action":"Monitor closely","effect":"May interact with Magnesium Oxide","source":"DrugCentral","drugSlug":"magnesium-oxide"},{"url":"/drug/nizatidine","drug":"nizatidine","action":"Monitor closely","effect":"May interact with Nizatidine","source":"DrugCentral","drugSlug":"nizatidine"},{"url":"/drug/ranitidine","drug":"ranitidine","action":"Monitor closely","effect":"May interact with Ranitidine","source":"DrugCentral","drugSlug":"ranitidine"},{"url":"/drug/sodium-bicarbonate","drug":"sodium bicarbonate","action":"Monitor closely","effect":"May interact with Sodium Bicarbonate","source":"DrugCentral","drugSlug":"sodium-bicarbonate"},{"url":"/drug/sucralfate","drug":"sucralfate","action":"Monitor closely","effect":"May interact with Sucralfate","source":"DrugCentral","drugSlug":"sucralfate"},{"url":"/drug/theophylline","drug":"theophylline","action":"Avoid combination","effect":"May interact with Theophylline","source":"DrugCentral","drugSlug":"theophylline"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ENOXACIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:55:17.037780+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:55:23.365578+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ENOXACIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:55:23.903199+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: DNA gyrase inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:55:24.944298+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL826/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:55:24.610890+00:00"}},"allNames":"enoksetin","offLabel":[],"synonyms":["enoxacin","enofloxacin","enofloxacine","enoksetin","enoxacine"],"timeline":[{"date":"1991-12-31","type":"positive","source":"DrugCentral","milestone":"FDA approval"}],"aiSummary":"Enoxacin, also known as Enoxacin, is a small molecule antibiotic in the enoxacin class that targets the TARBP2 subunit of the RISC-loading complex. It was originally developed and is currently owned by a pharmaceutical company. Enoxacin is FDA-approved for various indications related to gonorrhea and urinary tract infections. The drug has a bioavailability of 87% and a half-life of 5.1 hours. Enoxacin is off-patent, meaning it is no longer protected by patents.","approvals":[{"date":"1991-12-31","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Enoksetin","ecosystem":[{"indication":"Acute gonococcal cervicitis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"amphotericin B","slug":"amphotericin-b","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"azithromycin","slug":"azithromycin","company":""}],"globalPrevalence":null},{"indication":"Acute gonococcal urethritis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"amphotericin B","slug":"amphotericin-b","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"azithromycin","slug":"azithromycin","company":""}],"globalPrevalence":null},{"indication":"Gonorrhea","otherDrugs":[{"name":"amphotericin B","slug":"amphotericin-b","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"bacampicillin","slug":"bacampicillin","company":""},{"name":"cefixime","slug":"cefixime","company":""}],"globalPrevalence":null},{"indication":"Gonorrhea of pharynx","otherDrugs":[{"name":"amphotericin B","slug":"amphotericin-b","company":"Apothecon"},{"name":"ceftriaxone","slug":"ceftriaxone","company":""},{"name":"cefuroxime","slug":"cefuroxime","company":"Covis Injectables"},{"name":"demeclocycline","slug":"demeclocycline","company":"Lederle"}],"globalPrevalence":null},{"indication":"Gonorrhea of rectum","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"amphotericin B","slug":"amphotericin-b","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"cefpodoxime proxetil","slug":"cefpodoxime-proxetil","company":""}],"globalPrevalence":null},{"indication":"Urinary tract infectious disease","otherDrugs":[{"name":"Polymyxin B","slug":"polymyxin-b","company":"Monarch Pharms"},{"name":"acetohydroxamic acid","slug":"acetohydroxamic-acid","company":"Mission Pharma"},{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"amoxicillin","slug":"amoxicillin","company":"Apothecon"}],"globalPrevalence":null}],"mechanism":{"target":"RISC-loading complex subunit TARBP2","novelty":"Follow-on","targets":[{"gene":"TARBP2","source":"DrugCentral","target":"RISC-loading complex subunit TARBP2","protein":"RISC-loading complex subunit TARBP2"},{"gene":"ATP6V1B2","source":"DrugCentral","target":"V-type proton ATPase subunit B, brain isoform","protein":"V-type proton ATPase subunit B, brain isoform"}],"modality":"Small Molecule","drugClass":"enoxacin","explanation":"","oneSentence":"","technicalDetail":"Enoxacin specifically targets the bacterial enzyme DNA gyrase, a type II topoisomerase, which is essential for bacterial DNA replication and transcription. By inhibiting this enzyme, Enoxacin prevents the bacteria from replicating and ultimately leads to bacterial cell death."},"commercial":{"launchDate":"1991","_launchSource":"DrugCentral (FDA 1991-12-31, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1013","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=ENOXACIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ENOXACIN","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T10:56:39.463331","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:55:26.349484+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"ofloxacin","drugSlug":"ofloxacin","fdaApproval":"1990-12-28","genericCount":20,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ciprofloxacin","drugSlug":"ciprofloxacin","fdaApproval":"1987-10-22","patentExpiry":"Nov 27, 2038","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"norfloxacin","drugSlug":"norfloxacin","fdaApproval":"1986-10-31","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"lomefloxacin","drugSlug":"lomefloxacin","fdaApproval":"1992-02-21","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"sparfloxacin","drugSlug":"sparfloxacin","fdaApproval":"1996-12-19","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"grepafloxacin","drugSlug":"grepafloxacin","fdaApproval":"1997-11-06","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"levofloxacin","drugSlug":"levofloxacin","fdaApproval":"1996-12-20","genericCount":36,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"trovafloxacin","drugSlug":"trovafloxacin","fdaApproval":"1997-12-18","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"moxifloxacin","drugSlug":"moxifloxacin","fdaApproval":"1999-12-10","patentExpiry":"May 29, 2029","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"gemifloxacin","drugSlug":"gemifloxacin","fdaApproval":"2003-04-04","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"gatifloxacin","drugSlug":"gatifloxacin","fdaApproval":"2003-03-28","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"delafloxacin","drugSlug":"delafloxacin","fdaApproval":"2017-06-19","patentExpiry":"Sep 23, 2029","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"enoxacin","indications":{"approved":[{"name":"Acute gonococcal cervicitis","source":"DrugCentral","snomedId":20943002,"regulator":"FDA"},{"name":"Acute gonococcal urethritis","source":"DrugCentral","snomedId":29864006,"regulator":"FDA"},{"name":"Gonorrhea","source":"DrugCentral","snomedId":15628003,"regulator":"FDA"},{"name":"Gonorrhea of pharynx","source":"DrugCentral","snomedId":74372003,"regulator":"FDA"},{"name":"Gonorrhea of rectum","source":"DrugCentral","snomedId":42746002,"regulator":"FDA"},{"name":"Urinary tract infectious disease","source":"DrugCentral","snomedId":68566005,"regulator":"FDA"}],"offLabel":[{"name":"Chancroid","source":"DrugCentral","drugName":"ENOXACIN","evidenceCount":3,"evidenceLevel":"emerging"}],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"ofloxacin","brandName":"ofloxacin","genericName":"ofloxacin","approvalYear":"1990","relationship":"same-class"},{"drugId":"ciprofloxacin","brandName":"ciprofloxacin","genericName":"ciprofloxacin","approvalYear":"1987","relationship":"same-class"},{"drugId":"norfloxacin","brandName":"norfloxacin","genericName":"norfloxacin","approvalYear":"1986","relationship":"same-class"},{"drugId":"lomefloxacin","brandName":"lomefloxacin","genericName":"lomefloxacin","approvalYear":"1992","relationship":"same-class"},{"drugId":"sparfloxacin","brandName":"sparfloxacin","genericName":"sparfloxacin","approvalYear":"1996","relationship":"same-class"},{"drugId":"grepafloxacin","brandName":"grepafloxacin","genericName":"grepafloxacin","approvalYear":"1997","relationship":"same-class"},{"drugId":"levofloxacin","brandName":"levofloxacin","genericName":"levofloxacin","approvalYear":"1996","relationship":"same-class"},{"drugId":"trovafloxacin","brandName":"trovafloxacin","genericName":"trovafloxacin","approvalYear":"1997","relationship":"same-class"},{"drugId":"moxifloxacin","brandName":"moxifloxacin","genericName":"moxifloxacin","approvalYear":"1999","relationship":"same-class"},{"drugId":"gemifloxacin","brandName":"gemifloxacin","genericName":"gemifloxacin","approvalYear":"2003","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT04840823","phase":"PHASE1,PHASE2","title":"Enoxacin for Amyotrophic Lateral Sclerosis (ALS)","status":"COMPLETED","sponsor":"McGill University","startDate":"2021-03-26","conditions":["Amyotrophic Lateral Sclerosis"],"enrollment":8,"completionDate":"2023-11-15"},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":["Osteomyelitis"],"enrollment":11,"completionDate":"2018-11-07"},{"nctId":"NCT02305342","phase":"","title":"Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Family Physicians","status":"COMPLETED","sponsor":"Abbott","startDate":"2014-11","conditions":["Urinary Tract Infections (UTIs)"],"enrollment":350,"completionDate":"2015-02"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000148115","MMSL":"4658","NDDF":"003660","UNII":"325OGW249P","VUID":"4020144","CHEBI":"CHEBI:157175","VANDF":"4020144","INN_ID":"5351","RXNORM":"3925","UMLSCUI":"C0014310","chemblId":"CHEMBL826","ChEMBL_ID":"CHEMBL826","KEGG_DRUG":"D00310","DRUGBANK_ID":"DB00467","PUBCHEM_CID":"3229","SNOMEDCT_US":"387550004","IUPHAR_LIGAND_ID":"8882","MESH_DESCRIPTOR_UI":"D015365"},"formularyStatus":[],"_enricherVersion":"v2","_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"5.1 hours","clearance":"5.4 mL/min/kg","bioavailability":"87%","fractionUnbound":"0.8%","volumeOfDistribution":"2.0 L/kg"},"publicationCount":1162,"therapeuticAreas":["Infectious Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"J01MA04","allCodes":["J01MA04"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 25","pmid":"41883118","title":"In vitro and preclinical assessment of drug interactions between fluoroquinolones and a non-steroidal anti-inflammatory drug predicting risk of seizure.","journal":"Toxicological sciences : an official journal of the Society of Toxicology"},{"date":"2026 Mar 6","pmid":"41792996","title":"Cell-free miRNAs are pharmacodynamic biomarkers for enhanced DICER activity by enoxacin in human patients with ALS.","journal":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"date":"2026 Apr","pmid":"41765558","title":"Copper ion-antibiotic complexation inhibits photochemical transformation of fluoroquinolones via electron redistribution and reactivity regulation.","journal":"Journal of environmental sciences (China)"},{"date":"2026 Feb 26","pmid":"41748289","title":"Canonical microRNA loss drives tumor development implicating therapeutic efficacy of enoxacin in angiosarcoma.","journal":"RNA (New York, N.Y.)"},{"date":"2026 Mar 10","pmid":"41729907","title":"Flexible Organic Clip as an Adapter to Enhance Host-Guest Nanopore Single-Molecule Sensing.","journal":"Analytical chemistry"}],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1991","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1991-12-31T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:55:26.349484+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}